Editor-in-Chief Profile

Moritz Kircher

Moritz F. Kircher, MD, PhD
Chair, Department of Imaging
Director, Lurie Family Imaging Center
Director, Molecular Cancer Imaging Facility
Dana-Farber Cancer Institute &
Harvard Medical School
Chief, Division of Cancer Imaging,
Department of Radiology, Brigham Health



Dr. Moritz Kircher studied Medicine in his native country of Germany with a stint at Harvard Medical School and received his degrees from the Humboldt University in Berlin (Charité ­– Universitätsmedizin Berlin). After a postdoc at the Center for Molecular Imaging Research (CMIR) at Harvard Medical School – Massachusetts General Hospital (with Ralph Weissleder) from 2001-2004, he did his internship year in Surgery at the Cleveland Clinic, followed by a Residency in Diagnostic Radiology at Harvard Medical School – Beth Israel Deaconess Medical Center, where he also served as chief resident. This was followed by a clinical fellowship in Magnetic Resonance Imaging at Stanford University, where he also was a postdoc in the Molecular Imaging Program at Stanford (with Sam Gambhir) during the same year. In 2010, he joined the faculty of Memorial Sloan Kettering Cancer Center as an Assistant Professor. He was an Associate Professor at Cornell and the Gerstner Sloan Kettering Graduate School for Biomedical Sciences, an Associate Attending Radiologist in the Body Imaging Service, and an Associate Member at MSKCC. He also served as Associate Vice Chair for Research in the Department of Radiology. Dr. Kircher held a joint appointment with the Molecular Pharmacology Program of the Sloan Kettering Institute, where he was the head of the Kircher laboratory. He was a member of the Center for Molecular Imaging and Nanotechnology (CMINT) and the Brain Tumor Center of MSKCC. He maintains an active clinical practice as a Radiologist, which helps him guide his research into directions with the most pressing need for innovation.

In 2018, Dr. Kircher was named Chair of the Department of Imaging, Director of the Lurie Family Imaging Center, and Director of the Molecular Cancer Imaging Facility at the Dana-Farber Cancer Institute/Harvard Medical School, as well as Chief of the Division of Oncoradiology, Department of Radiology, Brigham Health.

Dr. Kircher's NIH funded research program focuses on the development of next generation multimodal imaging and theranostic probes, with a focus on "Surface-Enhanced Resonance Raman Scattering" (SERRS) nanoparticles. His lab is also interested in Multispectral Optoacoustic Tomography (MSOT), and pushes for the translation of these technologies into the clinics. He is the founding chair of the "Molecular Imaging in Nanotechnology and Theranostics" (MINT) Interest Group of the World Molecular Imaging Society (WMIS). Among the awards he has received for his research are the Dana Neuroscience Scholar Award, the Walter-Friedrich Award, the Pershing Square Sohn Prize, and the Damon Runyon-Rachleff Innovation Award.